Skip to main content
. 2016 Jun 30;32(3):92–100. doi: 10.3393/ac.2016.32.3.92

Table 3. Univariate and multivariate analyses to identify clinicopathologic parameters associated with progression-free survival.

graphic file with name ac-32-92-i003.jpg

PFS, progression-free survival; HR, hazard ratio; CI, confidence interval; CLM, colorectal-cancer liver metastases; group 1, number of liver metastases ≤ 2; group 2, number of liver metastases > 2 and ≤ 8; CEA, serum carcinoembryonic antigen; LVI, lymphovascular invasion.

*P < 0.05.